Skip to content

How Stress Leads to Premature Ovarian Insufficiency: An Elucidation of the Underlying Genetic Mechanisms

Investigation into the Association between DNA Methylation and Chronic Stress in Premature Ovarian Insufficiency

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500109615
Enrollment
Unknown
Registered
2025-09-23
Start date
2023-11-07
Completion date
Unknown
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Ovarian Insufficiency,Premature Ovarian Failure

Interventions

Healthy control group:NA
POI/POF group:NA

Sponsors

The International Peace Maternity and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
12 Years to 39 Years

Inclusion criteria

Inclusion criteria: 1. POI (Premature Ovarian Insufficiency) is diagnosed in women under 40 years of age who present with oligomenorrhea, hypomenorrhea, amenorrhea, or infertility, and have two consecutive baseline serum FSH levels >25 IU/L and <40 IU/L. 2. POF (Premature Ovarian Failure) is diagnosed in women under 40 years of age who experience menopause, accompanied by perimenopausal symptoms (such as hot flashes, night sweats, irritability, palpitations, insomnia, chest tightness, headaches, memory loss, lumbar and leg soreness, etc.), and have two consecutive baseline serum FSH levels =40 IU/L. 3. Tthe karyotype analysis must indicate a normal female karyotype, 46, 4. Testing for the FMR1 gene premutation (through assessment of FMRP, fragile X mental retardation protein) must yield negative results.

Exclusion criteria

Exclusion criteria: 1. Age over 40 years; 2. Post-chemotherapy for malignant tumors; 3. Patients with genetic factors or comorbid autoimmune diseases (e.g., hyperthyroidism, hypothyroidism, systemic lupus erythematosus); 4. Surgical factors (e.g., bilateral oophorectomy); 5. Patients with severe primary diseases of the cardiovascular, cerebrovascular, hepatic, renal, or hematopoietic systems, or psychiatric disorders.

Design outcomes

Primary

MeasureTime frame
Methylation detection;

Secondary

MeasureTime frame
Metabolic Markers;Chronic Stress Score;

Countries

China

Contacts

Public ContactDongmei Lai

The International Peace Maternity and Child Health Hospital

laidongmei@hotmail.com+86 21 64070434

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026